Curated News: National Center for Advancing Translational Sciences (NCATS)

Filters close
Newswise: Estrogen cream does not improve success rate for prolapse repair
Released: 15-Aug-2023 12:20 PM EDT
Estrogen cream does not improve success rate for prolapse repair
UT Southwestern Medical Center

Vaginal estrogen cream, which is commonly prescribed to help women after surgery for pelvic organ prolapse (POP), did not prevent a recurrence of the condition, according to results of a multicenter clinical trial led by UT Southwestern Medical Center. However, the medication did reduce symptoms of vaginal atrophy. The findings, reported in JAMA, could lead to new ways to improve outcomes of prolapse repairs, the study authors said.

Released: 7-Aug-2023 11:30 AM EDT
New Yale Study Shows Aerobic Exercise Relieves Pain for Ovarian Cancer Survivors
Yale Cancer Center/Smilow Cancer Hospital

One common side effect of treatment for ovarian cancer is chemotherapy-induced peripheral neuropathy (CIPN), which can damage peripheral nerves, causing severe pain and numbness. The effects can last for months – or even years — after completing chemotherapy. Currently, there is only one treatment with limited efficacy for CIPN.

Released: 25-Jul-2023 7:05 PM EDT
Older women at risk for Alzheimer’s disease may benefit from yoga
University of California, Los Angeles (UCLA), Health Sciences

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer’s disease and concerns about episodes of memory decline, according to a UCLA Health study.

Newswise: Genome Sequencing Nearly Twice as Effective as a Targeted Gene-Sequencing Test at Diagnosing Genetic Disorders in Newborns and Infants
10-Jul-2023 9:00 AM EDT
Genome Sequencing Nearly Twice as Effective as a Targeted Gene-Sequencing Test at Diagnosing Genetic Disorders in Newborns and Infants
Tufts University

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants.

Released: 9-Jun-2023 3:25 PM EDT
Study shows metformin lowers the risk of getting long COVID
University of Minnesota Medical School

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

Newswise: Mount Sinai Researchers Use New Deep Learning Approach to Enable Analysis of Electrocardiograms as Language
2-Jun-2023 12:35 PM EDT
Mount Sinai Researchers Use New Deep Learning Approach to Enable Analysis of Electrocardiograms as Language
Mount Sinai Health System

Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the accuracy and effectiveness of ECG-related diagnoses, especially for cardiac conditions where limited data is available on which to train. In a study published in the June 6 online issue of npj Digital Medicine DOI: 10.1038/s41746-023-00840-9, the team reported that its new deep learning model, known as HeartBEiT, forms a foundation upon which specialized diagnostic models can be created. The team noted that in comparison tests, models created using HeartBEiT surpassed established methods for ECG analysis.

Not for public release

This news release is embargoed until 2-Jun-2023 11:00 AM EDT Released to reporters: 1-Jun-2023 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2023 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Released: 24-May-2023 9:00 AM EDT
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Johns Hopkins Medicine

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

   
Newswise: Antibodies associated with rare disorder may signal future risk of heart attack and stroke
Released: 16-May-2023 8:05 AM EDT
Antibodies associated with rare disorder may signal future risk of heart attack and stroke
UT Southwestern Medical Center

Seemingly healthy people whose blood contained antibodies associated with a condition called antiphospholipid syndrome (APS) were significantly more likely to experience a cardiovascular event such as a heart attack or stroke than those without, a study led by UT Southwestern Medical Center scientists shows

Newswise: How love, health, and neighborhood intersect for Black Americans
Released: 11-May-2023 5:25 PM EDT
How love, health, and neighborhood intersect for Black Americans
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Romantic relationships and neighborhood quality are both important predictors of mental and emotional wellbeing. But the larger societal context also influences how these factors affect individuals. A new study from the University of Illinois looks at the intersection of relationships, neighborhood, and mental health for Black Americans.

10-May-2023 7:00 PM EDT
Annual Medicare spending could increase by $2 to $5 billion if Medicare expands coverage for dementia drug lecanemab
University of California, Los Angeles (UCLA), Health Sciences

The anti-dementia medication lecanemab and its ancillary costs could add $2 billion to $5 billion in annual Medicare spending if the Centers for Medicare and Medicaid Services (CMS) revise their coverage decision. Currently, the medication is covered only for patients who are enrolled in clinical trials.

Released: 11-May-2023 3:20 PM EDT
Sleep apnea associated with increased risk for long COVID
NYU Langone Health

Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health as home to the effort’s Clinical Science Core (CSC).

3-May-2023 8:20 PM EDT
UCLA researchers find possible link between self-perceived cognition deficits and symptomatic long COVID
University of California, Los Angeles (UCLA), Health Sciences

People who perceived that they had cognitive difficulties such as memory problems during COVID were more likely to have lingering physical manifestations of the disease than people who did not report cognitive issues.

Released: 23-Apr-2023 4:05 PM EDT
Achieving Prevention and Health, Rather Than More Healthcare
Rutgers University-New Brunswick

If more people have access to health insurance, we have to be sure the death rates of those with certain chronic conditions are decreasing.

Released: 10-Apr-2023 4:35 PM EDT
Identifying cancer genes’ multiple personalities
Cold Spring Harbor Laboratory

Mutations in our genes can lead to severe problems, like colon or liver cancer. But cancer is very complex. Mutations in the same genes can lead to different subtypes of tumors in different people. Currently, scientists don’t have a good way to produce such tumor subtypes for study in the lab.

Newswise: Black, Hispanic severe allergy patients less likely to receive allergy shots
Released: 6-Apr-2023 1:10 PM EDT
Black, Hispanic severe allergy patients less likely to receive allergy shots
Penn State College of Medicine

Penn State College of Medicine researchers have found Black and Hispanic patients with severe allergies are less likely to get a common treatment, allergen immunotherapy, compared to white patients.

Released: 31-Mar-2023 3:40 PM EDT
Fewer than 10% of patients screened for food insecurity during pandemic
University of California, Davis

As jobless rates rose during the COVID-19 pandemic, millions more Americans experienced food insecurity because they lacked consistent access to food. National health organizations recommend primary care providers screen patients for food insecurity, since not having access to enough food can lead to chronic diseases.

Released: 27-Mar-2023 7:40 PM EDT
Patients with septic shock benefit from a combination of hydrocortisone-fludrocortisone therapy
Boston University School of Medicine

A new study in JAMA Internal Medicine by researchers from Boston University Chobanian & Avedisian School of Medicine shows that patients receiving a combination of hydrocortisone and fludrocortisone had lower death rates and discharge to hospice compared to those who only received hydrocortisone.

Newswise: Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting
Released: 17-Mar-2023 12:30 PM EDT
Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting
University of North Carolina Health Care System

A four-year phase 2 clinical trial demonstrated that a peanut allergy treatment called sublingual immunotherapy, or SLIT, is effective and safe, while offering durable desensitization to peanuts in peanut-allergic children.

Released: 7-Mar-2023 4:20 PM EST
FDA mandate to limit acetaminophen in acetaminophen-opioid medications is associated with reduced serious liver injury
University of Alabama at Birmingham

A United States Food and Drug Administration mandate to limit the dosage of acetaminophen in pills that combine acetaminophen and opioid medications is significantly associated with subsequent reductions in serious liver injury.



close
1.9008